AI-generated from publicly available materials.Axtria is set to establish the largest AI engineering team dedicated to the pharmaceutical sector, aiming to reach 1,000 engineers by December 2026. This ambitious initiative is a response to the increasing demand for specialized talent capable of deploying AI solutions across various functions in life sciences.
Axtria's Forward Deployed Engineering (FDE) model, initiated about a year ago, focuses on the practical application of AI in complex enterprise environments. It emphasizes that success in the life sciences sector will hinge on effective implementation rather than merely having access to advanced AI models. Currently, FDE specialists are integrated within prominent life sciences firms, working on production-grade AI solutions that enhance both commercial and medical operations.
The life sciences industry has seen significant investments in data platforms and generative AI; however, there remains a notable gap in specialized talent capable of executing AI at an enterprise level. Axtria's FDE model aims to bridge this gap by merging AI engineering skills with in-depth life sciences knowledge, facilitating the transition from AI experimentation to large-scale deployment.
With engineers trained on major AI and cloud platforms, Axtria is also fostering development through the Axtria Institute, which transforms life sciences professionals into certified AI engineers. This strategic focus on talent development not only equips clients with specialists who understand both AI and life sciences but also reflects Axtria's commitment to advancing the industry's capabilities in AI deployment.